Horan Securities, Inc. - HALOZYME THERAPEUTICS INC ownership

HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 269 filers reported holding HALOZYME THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 0.26 and the average weighting 0.2%.

Quarter-by-quarter ownership
Horan Securities, Inc. ownership history of HALOZYME THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$9,595
-5.6%
2660.0%0.00%
-20.0%
Q1 2023$10,159
-32.9%
2660.0%0.01%
-44.4%
Q4 2022$15,135
+37.6%
2660.0%0.01%
+28.6%
Q3 2022$11,000
-15.4%
2660.0%0.01%
-12.5%
Q2 2022$13,000
+18.2%
2660.0%0.01%
+33.3%
Q1 2022$11,0000.0%2660.0%0.01%
-14.3%
Q4 2021$11,000
-8.3%
2660.0%0.01%
-22.2%
Q2 2021$12,000
+9.1%
2660.0%0.01%0.0%
Q1 2021$11,0000.0%2660.0%0.01%0.0%
Q4 2020$11,000
+57.1%
2660.0%0.01%
+28.6%
Q3 2020$7,0000.0%2660.0%0.01%
-12.5%
Q2 2020$7,000
+40.0%
2660.0%0.01%
+14.3%
Q1 2020$5,000
+25.0%
2660.0%0.01%
+75.0%
Q3 2019$4,000
-20.0%
2660.0%0.00%
-33.3%
Q2 2019$5,000
+25.0%
2660.0%0.01%
+50.0%
Q1 2019$4,0000.0%2660.0%0.00%
-20.0%
Q4 2018$4,0000.0%2660.0%0.01%
+25.0%
Q3 2018$4,000
-20.0%
2660.0%0.00%
-20.0%
Q2 2018$5,0000.0%2660.0%0.01%
+25.0%
Q1 2018$5,0000.0%2660.0%0.00%
-20.0%
Q4 2017$5,0000.0%2660.0%0.01%0.0%
Q3 2017$5,000
+66.7%
2660.0%0.01%
+66.7%
Q2 2017$3,0000.0%2660.0%0.00%0.0%
Q1 2017$3,000
+50.0%
2660.0%0.00%0.0%
Q3 2016$2,0002660.00%
Other shareholders
HALOZYME THERAPEUTICS INC shareholders Q2 2020
NameSharesValueWeighting ↓
Third Security, LLC 19,816,162$191,226,0008.73%
BB BIOTECH AG 6,825,532$65,866,0002.13%
Lombard Odier Asset Management (USA) Corp 2,700,000$26,055,0001.79%
SECTORAL ASSET MANAGEMENT INC 3,724,351$35,940,0001.61%
QVT Financial LP 2,010,186$19,398,0000.97%
JHL Capital Group LLC 1,475,000$14,234,0000.94%
MAZAMA CAPITAL MANAGEMENT INC 358,087$3,456,0000.79%
EcoR1 Capital, LLC 160,700$1,551,0000.78%
Alden Global Capital Ltd 332,500$3,209,0000.77%
IRIDIAN ASSET MANAGEMENT LLC/CT 7,274,065$70,195,0000.65%
View complete list of HALOZYME THERAPEUTICS INC shareholders